Finding the molecular switches behind new infectious diseases
Summary
Professor Clare Bryant at the University of Cambridge is using DeepMind's Co-Scientist to rapidly identify molecular switches that cause severe diseases like sepsis when pathogens jump between species, cutting research time from years to months.
View Cached Full Text
Cached at: 05/19/26, 07:15 PM
Similar Articles
Uniting biological toolkits for a new approach to ALS
DeepMind's Co-Scientist AI tool bridges the expertise of two researchers from different biological fields to accelerate ALS research by generating testable hypotheses and identifying RNA-based mechanisms for potential therapies.
Accelerating discovery of liver disease mechanisms
DeepMind's Co-Scientist AI system helped researchers at the University of Edinburgh generate a novel, experimentally verified hypothesis linking the NLRP3 inflammasome to the mechanism of drug resmetirom in MASH liver disease, potentially enabling targeted combination therapies.
Opening new paths in aging research
Calico Life Sciences uses Google DeepMind's Co‑Scientist to connect scattered findings in aging biology and generate testable hypotheses, such as a novel hypothesis about ISR regulation by metabolism.
Fast-tracking genetic leads to reverse cellular aging
DeepMind's Co-Scientist is helping biologists identify genetic factors that reverse cellular aging by mining literature and analyzing screening data, reducing analysis time from months to days.
@OpenAI: Rare disease diagnosis is challenging, as sequencing can surface millions of variants, and medical knowledge changes co…
OpenAI highlights how o3 Deep Research can aid rare disease diagnosis by integrating clinical features, inheritance patterns, variant evidence, and scientific literature into actionable hypotheses for specialists.